Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page
I’m liking the way this copromote is looking so far, the drug seems awesome, but it’s going to take a bit of time to build relationships with the docs, seems like that’s what matters.
I think these cardiologist are hard, all they want is data. Sure we’ve got pretty good data but I’m trying to build relationships here and they just want more data. Kinda frustrating but it’s still early so we will see how it works out. Definitely some pressure to make it happen.
Steve Nissen gave a great plug for us on Dr Radio this week, highlighting the data for primary prevention from the CLEAR study. The data is impressive and the double down on pcps makes sense for primary prevention. He really highlighted the unmet need for statin intolerance patients at about 15%, annd also the general under treatment for at risk people. It definitely put some extra pep in my step, lots of opportunities!
I’ve had several providers mention this to me this week, one heard the broadcast the other one had a patient ask about the drug. It definitely helps having support like this such as an expert to go on record to support the drug.
I had a guy mention this to me today. Apparently this Steve Nissan is a pretty big deal, definitely seem to carry a lot of weight with my guy, says he on board now.
I'm kicking ass with Nexletol and Nexlizet) code is 202 so at $40 deductible and most insurance is paying for it, Costco has been buying and CVS. My commissions are best ever to date thanks to this.
Not sure what code 202 is? Guessing it's your call sign. TIER 2 is a great $40 copay, good to see most insurance companies are paying for it. I think Esperion will do well this year, my commissions are rolling in nicely. I have been racking up the miles.
No pun intended, but I feel like we were a band aid for Esperion until it became clear they are getting the big CASH infusion from DS. They will be riding high with these assets and we helped bridge the gap. I’m thinking I may want to get on with this outfit as there is clearly a great looking path forward.